Skip to main content
Premium Trial:

Request an Annual Quote

VizX Sells GeneSifter to UCLA, Temple University, Joslin Diabetes Center, and Others in Q4

NEW YORK, Feb. 4 (GenomeWeb News) - Seattle-based VizX Labs said today that the University of California Los Angeles, Temple University, the Joslin Diabetes Center in Boston, Cardiff University, Wake Forest University, and Centre Hospitalier Universitaire de Montreal were among customers who purchased the company's flagship software product, GeneSifter, during the fourth quarter of 2004.

 

Financial details of the sales were not disclosed.

 

Sales of GeneSifter have broken records for the third quarter in row, the company said. The web-based bioinformatics tool used for analyzing microarray data was introduced in October 2002.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.